← Browse by Condition
Medical Condition
her 2 protein overexpression
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Enrollment
200 pts
Location
United States, South...
Sponsor
Jazz Pharmaceuticals
NCT04995003 Phase 1
Recruiting
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Enrollment
25 pts
Location
United States
Sponsor
Baylor College of Medicine